<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>consistency evaluation &#8211; Accestra Consulting</title>
	<atom:link href="https://www.accestra.com/tag/consistency-evaluation/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.accestra.com</link>
	<description>Your long term strategic partner for regulatory compliance.</description>
	<lastBuildDate>Fri, 19 Apr 2019 06:24:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.5.6</generator>

<image>
	<url>https://www.accestra.com/wp-content/uploads/2019/03/cropped-accestra2-32x32.png</url>
	<title>consistency evaluation &#8211; Accestra Consulting</title>
	<link>https://www.accestra.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Updates of Generic Drug Consistency Evaluation Work in China</title>
		<link>https://www.accestra.com/updates-of-generic-drug-consistency-evaluation-work-in-china/</link>
		
		<dc:creator><![CDATA[mona.zhang]]></dc:creator>
		<pubDate>Wed, 06 Mar 2019 02:00:27 +0000</pubDate>
				<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[BE]]></category>
		<category><![CDATA[China CDE]]></category>
		<category><![CDATA[consistency evaluation]]></category>
		<guid isPermaLink="false">http://www.accestra.com/?p=1901</guid>

					<description><![CDATA[Until February 13th, 2019, the China Center of Drug Evaluation, National Medical Products Administration (CDE-NMPA) has announced 126 drugs’ information which passed the consistency evaluation on its website. The public information includes the basic information of drugs and companies, the BE test data and product specifications. According to the third-party statistics, the total number of&#8230;]]></description>
										<content:encoded><![CDATA[<p>Until February 13<sup>th</sup>, 2019, the China Center of Drug Evaluation, National Medical Products Administration (CDE-NMPA) has announced 126 drugs’ information which passed the consistency evaluation on its website. The public information includes the basic information of drugs and companies, the BE test data and product specifications. According to the third-party statistics, the total number of acceptances for consistency evaluation by CDE-NMPA has reached 906, including 290 varieties of 309 companies.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
